Acute neuroactive steroid withdrawal in withdrawal seizure-prone and withdrawal seizure-resistant mice

Matthew T. Reilly, John Jr Crabbe, Nathan R. Rustay, Deborah (Deb) Finn

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is an endogenously derived metabolite of progesterone, and a potent positive modulator of γ-aminobutyric acidA (GABAA) receptors. A withdrawal syndrome, characterized by central nervous system (CNS) hyperexcitability, has been demonstrated following abrupt discontinuation of high progesterone levels in rats, which was due in part to altered levels of allopregnanolone. The purpose of the present study was to determine if a single administration of pregnanolone or allopregnanolone could produce an acute withdrawal response in mice selected for susceptibility (Withdrawal Seizure-Prone, WSP) or resistance (Withdrawal Seizure-Resistant, WSR) to ethanol withdrawal convulsions. WSP mice administered 75 mg/kg pregnanolone showed a significant increase in handling-induced convulsion (HIC) scores over a 25-h testing period. In contrast, HIC scores in WSR mice were negligible after acute administration of 25, 50, 75, or 100 mg/kg pregnanolone. WSP mice also showed a similar increase in HIC after withdrawal from 75 mg/kg allopregnanolone. This effect was evident at both the 10-h and 25-h overall withdrawal severity assessment. These results demonstrate that neuroactive steroids can elicit an acute withdrawal response similar to that of other positive modulators of GABAA receptors in WSP mice, supporting the notion that a common set of genes underlie acute and chronic withdrawal severity from multiple agents with depressant effects on the central nervous system.

Original languageEnglish (US)
Pages (from-to)709-717
Number of pages9
JournalPharmacology Biochemistry and Behavior
Volume67
Issue number4
DOIs
StatePublished - 2000

Fingerprint

Pregnanolone
Seizures
Steroids
Neurology
GABA-A Receptors
Modulators
Progesterone
Central Nervous System
Metabolites
Rats
Ethanol
Genes
Testing

Keywords

  • Acute withdrawal
  • Allopregnanolone
  • Ethanol
  • Neurosteroids
  • Selected lines
  • WSP
  • WSR

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology

Cite this

Acute neuroactive steroid withdrawal in withdrawal seizure-prone and withdrawal seizure-resistant mice. / Reilly, Matthew T.; Crabbe, John Jr; Rustay, Nathan R.; Finn, Deborah (Deb).

In: Pharmacology Biochemistry and Behavior, Vol. 67, No. 4, 2000, p. 709-717.

Research output: Contribution to journalArticle

@article{fec188d5a8d64b34ac7a797ff4d73489,
title = "Acute neuroactive steroid withdrawal in withdrawal seizure-prone and withdrawal seizure-resistant mice",
abstract = "Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is an endogenously derived metabolite of progesterone, and a potent positive modulator of γ-aminobutyric acidA (GABAA) receptors. A withdrawal syndrome, characterized by central nervous system (CNS) hyperexcitability, has been demonstrated following abrupt discontinuation of high progesterone levels in rats, which was due in part to altered levels of allopregnanolone. The purpose of the present study was to determine if a single administration of pregnanolone or allopregnanolone could produce an acute withdrawal response in mice selected for susceptibility (Withdrawal Seizure-Prone, WSP) or resistance (Withdrawal Seizure-Resistant, WSR) to ethanol withdrawal convulsions. WSP mice administered 75 mg/kg pregnanolone showed a significant increase in handling-induced convulsion (HIC) scores over a 25-h testing period. In contrast, HIC scores in WSR mice were negligible after acute administration of 25, 50, 75, or 100 mg/kg pregnanolone. WSP mice also showed a similar increase in HIC after withdrawal from 75 mg/kg allopregnanolone. This effect was evident at both the 10-h and 25-h overall withdrawal severity assessment. These results demonstrate that neuroactive steroids can elicit an acute withdrawal response similar to that of other positive modulators of GABAA receptors in WSP mice, supporting the notion that a common set of genes underlie acute and chronic withdrawal severity from multiple agents with depressant effects on the central nervous system.",
keywords = "Acute withdrawal, Allopregnanolone, Ethanol, Neurosteroids, Selected lines, WSP, WSR",
author = "Reilly, {Matthew T.} and Crabbe, {John Jr} and Rustay, {Nathan R.} and Finn, {Deborah (Deb)}",
year = "2000",
doi = "10.1016/S0091-3057(00)00416-0",
language = "English (US)",
volume = "67",
pages = "709--717",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Acute neuroactive steroid withdrawal in withdrawal seizure-prone and withdrawal seizure-resistant mice

AU - Reilly, Matthew T.

AU - Crabbe, John Jr

AU - Rustay, Nathan R.

AU - Finn, Deborah (Deb)

PY - 2000

Y1 - 2000

N2 - Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is an endogenously derived metabolite of progesterone, and a potent positive modulator of γ-aminobutyric acidA (GABAA) receptors. A withdrawal syndrome, characterized by central nervous system (CNS) hyperexcitability, has been demonstrated following abrupt discontinuation of high progesterone levels in rats, which was due in part to altered levels of allopregnanolone. The purpose of the present study was to determine if a single administration of pregnanolone or allopregnanolone could produce an acute withdrawal response in mice selected for susceptibility (Withdrawal Seizure-Prone, WSP) or resistance (Withdrawal Seizure-Resistant, WSR) to ethanol withdrawal convulsions. WSP mice administered 75 mg/kg pregnanolone showed a significant increase in handling-induced convulsion (HIC) scores over a 25-h testing period. In contrast, HIC scores in WSR mice were negligible after acute administration of 25, 50, 75, or 100 mg/kg pregnanolone. WSP mice also showed a similar increase in HIC after withdrawal from 75 mg/kg allopregnanolone. This effect was evident at both the 10-h and 25-h overall withdrawal severity assessment. These results demonstrate that neuroactive steroids can elicit an acute withdrawal response similar to that of other positive modulators of GABAA receptors in WSP mice, supporting the notion that a common set of genes underlie acute and chronic withdrawal severity from multiple agents with depressant effects on the central nervous system.

AB - Allopregnanolone (3α-hydroxy-5α-pregnan-20-one) is an endogenously derived metabolite of progesterone, and a potent positive modulator of γ-aminobutyric acidA (GABAA) receptors. A withdrawal syndrome, characterized by central nervous system (CNS) hyperexcitability, has been demonstrated following abrupt discontinuation of high progesterone levels in rats, which was due in part to altered levels of allopregnanolone. The purpose of the present study was to determine if a single administration of pregnanolone or allopregnanolone could produce an acute withdrawal response in mice selected for susceptibility (Withdrawal Seizure-Prone, WSP) or resistance (Withdrawal Seizure-Resistant, WSR) to ethanol withdrawal convulsions. WSP mice administered 75 mg/kg pregnanolone showed a significant increase in handling-induced convulsion (HIC) scores over a 25-h testing period. In contrast, HIC scores in WSR mice were negligible after acute administration of 25, 50, 75, or 100 mg/kg pregnanolone. WSP mice also showed a similar increase in HIC after withdrawal from 75 mg/kg allopregnanolone. This effect was evident at both the 10-h and 25-h overall withdrawal severity assessment. These results demonstrate that neuroactive steroids can elicit an acute withdrawal response similar to that of other positive modulators of GABAA receptors in WSP mice, supporting the notion that a common set of genes underlie acute and chronic withdrawal severity from multiple agents with depressant effects on the central nervous system.

KW - Acute withdrawal

KW - Allopregnanolone

KW - Ethanol

KW - Neurosteroids

KW - Selected lines

KW - WSP

KW - WSR

UR - http://www.scopus.com/inward/record.url?scp=0034486303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034486303&partnerID=8YFLogxK

U2 - 10.1016/S0091-3057(00)00416-0

DO - 10.1016/S0091-3057(00)00416-0

M3 - Article

C2 - 11166061

AN - SCOPUS:0034486303

VL - 67

SP - 709

EP - 717

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -